Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis

BACKGROUND: Abatacept (ABA) is a biological disease-modifying antirheumatic drug (bDMARD) for rheumatoid arthritis (RA). The aim of this study was to identify molecules that are associated with therapeutic responses to ABA in patients with RA. METHODS: Peripheral blood was collected using a PAX gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoyama-Kokuryo, Waka, Yamazaki, Hayato, Takeuchi, Tsutomu, Amano, Koichi, Kikuchi, Jun, Kondo, Tsuneo, Nakamura, Seiji, Sakai, Ryoko, Hirano, Fumio, Nanki, Toshihiro, Koike, Ryuji, Harigai, Masayoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068901/
https://www.ncbi.nlm.nih.gov/pubmed/32164778
http://dx.doi.org/10.1186/s13075-020-2137-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068901/
https://www.ncbi.nlm.nih.gov/pubmed/32164778
http://dx.doi.org/10.1186/s13075-020-2137-y

Ejemplares similares